KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Resmed (RMD) Leases (2019 - 2025)

Resmed's Leases history spans 7 years, with the latest figure at $165.9 million for Q4 2025.

  • For Q4 2025, Leases rose 9.87% year-over-year to $165.9 million; the TTM value through Dec 2025 reached $165.9 million, up 9.87%, while the annual FY2025 figure was $167.5 million, 10.84% up from the prior year.
  • Leases reached $165.9 million in Q4 2025 per RMD's latest filing, up from $162.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $167.5 million in Q2 2025 to a low of $123.4 million in Q3 2023.
  • Average Leases over 5 years is $142.6 million, with a median of $143.6 million recorded in 2021.
  • Peak YoY movement for Leases: decreased 12.2% in 2022, then increased 27.27% in 2024.
  • A 5-year view of Leases shows it stood at $146.0 million in 2021, then fell by 12.2% to $128.2 million in 2022, then grew by 19.69% to $153.5 million in 2023, then fell by 1.6% to $151.0 million in 2024, then rose by 9.87% to $165.9 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Leases are $165.9 million (Q4 2025), $162.0 million (Q3 2025), and $167.5 million (Q2 2025).